Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity
- PMID: 3584988
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity
Abstract
Our studies and other investigations have shown that NK effector cells can also mediate antibody-dependent cellular cytotoxicity (ADCC) through the use of the Fc gamma receptor on the NK cell membrane. Peripheral blood lymphocytes (PBL) derived from patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex exhibit a poor NK activity due to a defective "trigger" required for activation in the lethal hit stage of the NK lytic pathway. Consequently, it was important to delineate whether the defect in AIDS NK cells affected the ADCC function. By using the 51Cr-release assay, the ADCC cytotoxic activity of AIDS PBL was found to be within the normal range, despite the absence of significant NK activity. Several experiments corroborated that the same effector cells mediate both NK CMC and ADCC. Depletion of Fc gamma R-bearing cells resulted in elimination of both the ADCC and NK cytotoxic functions. Single cell analyses, using one- and two-target cell conjugates, revealed that the frequency of ADCC effector:target conjugates and the frequency of killer cells from AIDS PBL were comparable to the frequencies seen in the normal controls. However, when mixtures of NK and ADCC targets were used to form mixed two-target conjugates, the AIDS effector cells lysed only the bound ADCC target, whereas the normal effector cells lysed both the bound NK and ADCC targets. These results demonstrate clearly that the same NK/K effector cells from AIDS PBL, defective in NK activity, are not impaired in mediating ADCC activity. These findings were supported by the demonstration that AIDS PBL stimulated with ADCC targets, but not with NK targets, released NK cytotoxic factors, postulated mediators of the NK CMC reaction. These findings indicate that the NK/K cells in AIDS are triggered normally for ADCC activity but are not triggered for NK activity. Furthermore, the results indicate that the lytic machinery is not impaired in the AIDS NK/K cells.
Similar articles
-
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.J Immunol. 1986 Aug 15;137(4):1157-63. J Immunol. 1986. PMID: 3488345
-
Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.J Immunol. 1984 Feb;132(2):594-8. J Immunol. 1984. PMID: 6606675
-
Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.J Immunol. 1990 May 1;144(9):3375-84. J Immunol. 1990. PMID: 2329275
-
Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.J Natl Cancer Inst. 1979 Oct;63(4):995-1003. J Natl Cancer Inst. 1979. PMID: 384012 Review.
-
Anti-HIV-1 ADCC: clinical and therapeutic implications.Biotechnol Ther. 1991;2(1-2):147-57. Biotechnol Ther. 1991. PMID: 1845118 Review.
Cited by
-
Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?Front Immunol. 2015 May 27;6:265. doi: 10.3389/fimmu.2015.00265. eCollection 2015. Front Immunol. 2015. PMID: 26074924 Free PMC article. Review. No abstract available.
-
Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.J Clin Immunol. 1989 Nov;9(6):454-61. doi: 10.1007/BF00918014. J Clin Immunol. 1989. PMID: 2576558 Clinical Trial.
-
Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus.J Clin Microbiol. 1989 Jan;27(1):41-8. doi: 10.1128/jcm.27.1.41-48.1989. J Clin Microbiol. 1989. PMID: 2913035 Free PMC article.
-
Expression of human immunodeficiency virus genes using baculovirus expression system.Mol Biotechnol. 1997 Oct;8(2):173-87. doi: 10.1007/BF02752262. Mol Biotechnol. 1997. PMID: 9406188
-
Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.Clin Exp Immunol. 1989 Feb;75(2):184-9. Clin Exp Immunol. 1989. PMID: 2649286 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical